CrossRef Glucagon-Like Peptide-1 Receptor Agonists Combined With Personalized Digital Health Care for the Treatment of Metabolic Syndrome in Adults With Obesity: Retrospective Observational Study Hala Zakaria, Hadoun Jabri, Sheikha Alshehhi, Milena Caccelli, Joelle Debs, Yousef Said, Joudy Kattan, Noah Almarzooqi, Ali Hashemi, Ihsan Almarzooqi Interactive Journal of Medical Research.2025
Its fluid texture with colour minimises the white residue
Furthermore, when we performed GSEA for each of the chondrocyte differentiation stages separately, we observed that among the three upregulated pathways, protein processing in ER was ranked highest in resting chondrocytes, but proteasome was top-ranked in columnar and ferroptosis in hypertrophic chondrocytes, suggesting that the phenotype progressively evolves during chondrocyte differentiation from a homeostatic adaptive response to cell death (Extended Data Fig
As of 2023, no GLP-1 transdermal systems have completed Phase 3 clinical trials or received regulatory approval
Vision changes during GLP-1 therapy typically stem from secondary factors rather than direct drug action on the eye
